In the ongoing search to find a pain intervention that does away with the need for opioids – and bypasses drugs altogether – ...

Historically linked to an anti-duelling group, Daniel O’Connell and the East India Company, today properties on ‘the Green’ house the offices of global corporations, an online retail giant and private ...

NGG is a solid investment pick due to its earnings growth projections, systematic capital expenditure plan and large-scale renewable energy projects.

Standard & Poor’s endorses Greece’s plan to repay first bailout loans early, projecting no impact on the country’s credit ...

ES targets $24.2 billion in capital upgrades by 2029, boosting grid reliability and advancing New England's clean energy shift.

The Meghalaya cabinet has sanctioned direct land acquisition for expanding Shillong Airport's runway, approving compensation ...

The international credit rating agency Standard & Poor’s has given the green light-albeit indirectly-for the early repayment ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for TransCon ® CNP (navepegritide) for the treatment of children with achondroplasia ...

TransCon CNP is an investigational prodrug of C-type natriuretic peptide (CNP) administered once weekly and designed to treat people living with achondroplasia by providing continuous exposure of ...